Skip to main content
An official website of the United States government
Principal Investigator
Lisa (Nmn) Bailey
Awardee Organization

Bay Area Tumor Institute
United States

Fiscal Year
2023
Activity Code
UG1
Early Stage Investigator Grants (ESI)
Not Applicable
Project End Date

Bay Area Tumor Institute NCI Community Oncology Research Program (NCORP) Community Sites

This BATI-NCORP program is designed to provide cancer patients, and healthy citizens “at risk” for cancer, with opportunities to participate in NCI-sponsored clinical trials developed by the members of the National Clinical Trials Network (NCTN) and NCORP Research Bases. These clinical trials are intended to identify more effective and/or less toxic treatments for the prevention, detection, diagnosis, treatment, long-term supportive care, or end-of-life care for cancer patients. Via the BATI-NCORP, East Bay oncologists can provide their patients, at no cost, with opportunities to participate in the most advanced and promising forms of genetic therapy, immunotherapy, chemotherapy, surgery and radiation treatments.

Publications

  • Herbst RS, Redman MW, Kim ES, Semrad TJ, Bazhenova L, Masters G, Oettel K, Guaglianone P, Reynolds C, Karnad A, Arnold SM, Varella-Garcia M, Moon J, Mack PC, Blanke CD, Hirsch FR, Kelly K, Gandara DR. Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study. The Lancet. Oncology. 2018 Jan;19(1):101-114. Epub 2017 Nov 20. PMID: 29169877
  • Nahleh ZA, Barlow WE, Hayes DF, Schott AF, Gralow JR, Sikov WM, Perez EA, Chennuru S, Mirshahidi HR, Corso SW, Lew DL, Pusztai L, Livingston RB, Hortobagyi GN. SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer. Breast cancer research and treatment. 2016 Aug;158(3):485-95. Epub 2016 Jul 8. PMID: 27393622
  • Vaidya R, Unger JM, Loomba R, Hwang JP, Chugh R, Tincopa MA, Arnold KB, Hershman DL, Ramsey SD. Universal Viral Screening of Patients with Newly Diagnosed Cancer in the United States: A Cost-efficiency Evaluation. Cancer research communications. 2023 Sep 28;3(9):1959-1965. PMID: 37707388
  • Unger JM, Hershman DL, Arnold KB, Loomba R, Chugh R, Hwang JP, O'Rourke MA, Bhadkamkar NA, Wang LX, Siegel AB, Cooley TP, Berenberg JL, Bridges BB, Ramsey SD. Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patients. Future oncology (London, England). 2016 May;12(10):1219-31. Epub 2016 Mar 8. PMID: 26952901